GSK says tests hint COVID drug fights Omicron

Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant, the British drugmaker said on Thursday. Conway G. Gittens reports.

from news.com.au — Australia’s leading news site https://ift.tt/3pp3AFt
https://ift.tt/eA8V8J
December 03, 2021 at 12:35AM
Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant, the British drugmaker said on Thursday. Conway G. Gittens reports.